-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENAS BIOPHARMA SHARES HIT MORE THAN FOUR-MONTH LOW AFTER LATE-STAGE DATA FOR IMMUNE DISORDER DRUG, LAST DOWN 55%

Reuters·01/05/2026 15:26:25

Please log in to view news